ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global RNA Interference Technology Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-38X12576
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global RNA Interference Technology Market Research Report 2022
BUY CHAPTERS

Global RNA Interference Technology Market Research Report 2025

Code: QYRE-Auto-38X12576
Report
March 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Alnylam Pharmaceuticals
Arrowhead Pharmaceuticals
Astrazeneca plc
Bioneer Corporation
CureVac N.V.
Dicerna Pharmaceuticals
Gradalis Inc
Ionis Pharmaceuticals
Merck KGaA
Nutcracker Therapeutics
Phio Pharmaceuticals
Sirnaomics
Arcturus Therapeutics Holdings
Atalanta Therapeutics

RNA Interference Technology Market

The global market for RNA Interference Technology was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for RNA Interference Technology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for RNA Interference Technology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of RNA Interference Technology include Alnylam Pharmaceuticals, Arcturus Therapeutics Holdings, Arrowhead Pharmaceuticals, AstraZeneca, Atalanta Therapeutics, Bioneer Corporation, CureVac N.V., Dicerna Pharmaceuticals, Gradalis, Ionis Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for RNA Interference Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA Interference Technology.
The RNA Interference Technology market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global RNA Interference Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the RNA Interference Technology manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of RNA Interference Technology Market Report

Report Metric Details
Report Name RNA Interference Technology Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Alnylam Pharmaceuticals, Arcturus Therapeutics Holdings, Arrowhead Pharmaceuticals, AstraZeneca, Atalanta Therapeutics, Bioneer Corporation, CureVac N.V., Dicerna Pharmaceuticals, Gradalis, Ionis Pharmaceuticals, Merck KGaA, Nutcracker Therapeutics, Phio Pharmaceuticals, Sirnaomics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of RNA Interference Technology manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of RNA Interference Technology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the RNA Interference Technology Market report?

Ans: The main players in the RNA Interference Technology Market are Alnylam Pharmaceuticals, Arcturus Therapeutics Holdings, Arrowhead Pharmaceuticals, AstraZeneca, Atalanta Therapeutics, Bioneer Corporation, CureVac N.V., Dicerna Pharmaceuticals, Gradalis, Ionis Pharmaceuticals, Merck KGaA, Nutcracker Therapeutics, Phio Pharmaceuticals, Sirnaomics

What are the Application segmentation covered in the RNA Interference Technology Market report?

Ans: The Applications covered in the RNA Interference Technology Market report are Drug Discovery and Development, Diagnostic Centers, Others

What are the Type segmentation covered in the RNA Interference Technology Market report?

Ans: The Types covered in the RNA Interference Technology Market report are dsRNA, miRNA

Recommended Reports

RNA Research Technologies

Gene Therapy & Diagnostics

RNA Therapies & Extraction

1 RNA Interference Technology Market Overview
1.1 Product Definition
1.2 RNA Interference Technology by Type
1.2.1 Global RNA Interference Technology Market Value Comparison by Type (2024 VS 2031)
1.2.2 dsRNA
1.2.3 miRNA
1.3 RNA Interference Technology by Application
1.3.1 Global RNA Interference Technology Market Value by Application (2024 VS 2031)
1.3.2 Drug Discovery and Development
1.3.3 Diagnostic Centers
1.3.4 Others
1.4 Global RNA Interference Technology Market Size Estimates and Forecasts
1.4.1 Global RNA Interference Technology Revenue 2020-2031
1.4.2 Global RNA Interference Technology Sales 2020-2031
1.4.3 Global RNA Interference Technology Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 RNA Interference Technology Market Competition by Manufacturers
2.1 Global RNA Interference Technology Sales Market Share by Manufacturers (2020-2025)
2.2 Global RNA Interference Technology Revenue Market Share by Manufacturers (2020-2025)
2.3 Global RNA Interference Technology Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of RNA Interference Technology, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of RNA Interference Technology, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of RNA Interference Technology, Product Type & Application
2.7 Global Key Manufacturers of RNA Interference Technology, Date of Enter into This Industry
2.8 Global RNA Interference Technology Market Competitive Situation and Trends
2.8.1 Global RNA Interference Technology Market Concentration Rate
2.8.2 The Global 5 and 10 Largest RNA Interference Technology Players Market Share by Revenue
2.8.3 Global RNA Interference Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global RNA Interference Technology Market Scenario by Region
3.1 Global RNA Interference Technology Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global RNA Interference Technology Sales by Region: 2020-2031
3.2.1 Global RNA Interference Technology Sales by Region: 2020-2025
3.2.2 Global RNA Interference Technology Sales by Region: 2026-2031
3.3 Global RNA Interference Technology Revenue by Region: 2020-2031
3.3.1 Global RNA Interference Technology Revenue by Region: 2020-2025
3.3.2 Global RNA Interference Technology Revenue by Region: 2026-2031
3.4 North America RNA Interference Technology Market Facts & Figures by Country
3.4.1 North America RNA Interference Technology Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America RNA Interference Technology Sales by Country (2020-2031)
3.4.3 North America RNA Interference Technology Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe RNA Interference Technology Market Facts & Figures by Country
3.5.1 Europe RNA Interference Technology Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe RNA Interference Technology Sales by Country (2020-2031)
3.5.3 Europe RNA Interference Technology Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific RNA Interference Technology Market Facts & Figures by Region
3.6.1 Asia Pacific RNA Interference Technology Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific RNA Interference Technology Sales by Region (2020-2031)
3.6.3 Asia Pacific RNA Interference Technology Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America RNA Interference Technology Market Facts & Figures by Country
3.7.1 Latin America RNA Interference Technology Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America RNA Interference Technology Sales by Country (2020-2031)
3.7.3 Latin America RNA Interference Technology Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa RNA Interference Technology Market Facts & Figures by Country
3.8.1 Middle East and Africa RNA Interference Technology Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa RNA Interference Technology Sales by Country (2020-2031)
3.8.3 Middle East and Africa RNA Interference Technology Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global RNA Interference Technology Sales by Type (2020-2031)
4.1.1 Global RNA Interference Technology Sales by Type (2020-2025)
4.1.2 Global RNA Interference Technology Sales by Type (2026-2031)
4.1.3 Global RNA Interference Technology Sales Market Share by Type (2020-2031)
4.2 Global RNA Interference Technology Revenue by Type (2020-2031)
4.2.1 Global RNA Interference Technology Revenue by Type (2020-2025)
4.2.2 Global RNA Interference Technology Revenue by Type (2026-2031)
4.2.3 Global RNA Interference Technology Revenue Market Share by Type (2020-2031)
4.3 Global RNA Interference Technology Price by Type (2020-2031)
5 Segment by Application
5.1 Global RNA Interference Technology Sales by Application (2020-2031)
5.1.1 Global RNA Interference Technology Sales by Application (2020-2025)
5.1.2 Global RNA Interference Technology Sales by Application (2026-2031)
5.1.3 Global RNA Interference Technology Sales Market Share by Application (2020-2031)
5.2 Global RNA Interference Technology Revenue by Application (2020-2031)
5.2.1 Global RNA Interference Technology Revenue by Application (2020-2025)
5.2.2 Global RNA Interference Technology Revenue by Application (2026-2031)
5.2.3 Global RNA Interference Technology Revenue Market Share by Application (2020-2031)
5.3 Global RNA Interference Technology Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Alnylam Pharmaceuticals
6.1.1 Alnylam Pharmaceuticals Company Information
6.1.2 Alnylam Pharmaceuticals Description and Business Overview
6.1.3 Alnylam Pharmaceuticals RNA Interference Technology Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Alnylam Pharmaceuticals RNA Interference Technology Product Portfolio
6.1.5 Alnylam Pharmaceuticals Recent Developments/Updates
6.2 Arcturus Therapeutics Holdings
6.2.1 Arcturus Therapeutics Holdings Company Information
6.2.2 Arcturus Therapeutics Holdings Description and Business Overview
6.2.3 Arcturus Therapeutics Holdings RNA Interference Technology Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Arcturus Therapeutics Holdings RNA Interference Technology Product Portfolio
6.2.5 Arcturus Therapeutics Holdings Recent Developments/Updates
6.3 Arrowhead Pharmaceuticals
6.3.1 Arrowhead Pharmaceuticals Company Information
6.3.2 Arrowhead Pharmaceuticals Description and Business Overview
6.3.3 Arrowhead Pharmaceuticals RNA Interference Technology Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Arrowhead Pharmaceuticals RNA Interference Technology Product Portfolio
6.3.5 Arrowhead Pharmaceuticals Recent Developments/Updates
6.4 AstraZeneca
6.4.1 AstraZeneca Company Information
6.4.2 AstraZeneca Description and Business Overview
6.4.3 AstraZeneca RNA Interference Technology Sales, Revenue and Gross Margin (2020-2025)
6.4.4 AstraZeneca RNA Interference Technology Product Portfolio
6.4.5 AstraZeneca Recent Developments/Updates
6.5 Atalanta Therapeutics
6.5.1 Atalanta Therapeutics Company Information
6.5.2 Atalanta Therapeutics Description and Business Overview
6.5.3 Atalanta Therapeutics RNA Interference Technology Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Atalanta Therapeutics RNA Interference Technology Product Portfolio
6.5.5 Atalanta Therapeutics Recent Developments/Updates
6.6 Bioneer Corporation
6.6.1 Bioneer Corporation Company Information
6.6.2 Bioneer Corporation Description and Business Overview
6.6.3 Bioneer Corporation RNA Interference Technology Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bioneer Corporation RNA Interference Technology Product Portfolio
6.6.5 Bioneer Corporation Recent Developments/Updates
6.7 CureVac N.V.
6.7.1 CureVac N.V. Company Information
6.7.2 CureVac N.V. Description and Business Overview
6.7.3 CureVac N.V. RNA Interference Technology Sales, Revenue and Gross Margin (2020-2025)
6.7.4 CureVac N.V. RNA Interference Technology Product Portfolio
6.7.5 CureVac N.V. Recent Developments/Updates
6.8 Dicerna Pharmaceuticals
6.8.1 Dicerna Pharmaceuticals Company Information
6.8.2 Dicerna Pharmaceuticals Description and Business Overview
6.8.3 Dicerna Pharmaceuticals RNA Interference Technology Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Dicerna Pharmaceuticals RNA Interference Technology Product Portfolio
6.8.5 Dicerna Pharmaceuticals Recent Developments/Updates
6.9 Gradalis
6.9.1 Gradalis Company Information
6.9.2 Gradalis Description and Business Overview
6.9.3 Gradalis RNA Interference Technology Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Gradalis RNA Interference Technology Product Portfolio
6.9.5 Gradalis Recent Developments/Updates
6.10 Ionis Pharmaceuticals
6.10.1 Ionis Pharmaceuticals Company Information
6.10.2 Ionis Pharmaceuticals Description and Business Overview
6.10.3 Ionis Pharmaceuticals RNA Interference Technology Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Ionis Pharmaceuticals RNA Interference Technology Product Portfolio
6.10.5 Ionis Pharmaceuticals Recent Developments/Updates
6.11 Merck KGaA
6.11.1 Merck KGaA Company Information
6.11.2 Merck KGaA Description and Business Overview
6.11.3 Merck KGaA RNA Interference Technology Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Merck KGaA RNA Interference Technology Product Portfolio
6.11.5 Merck KGaA Recent Developments/Updates
6.12 Nutcracker Therapeutics
6.12.1 Nutcracker Therapeutics Company Information
6.12.2 Nutcracker Therapeutics Description and Business Overview
6.12.3 Nutcracker Therapeutics RNA Interference Technology Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Nutcracker Therapeutics RNA Interference Technology Product Portfolio
6.12.5 Nutcracker Therapeutics Recent Developments/Updates
6.13 Phio Pharmaceuticals
6.13.1 Phio Pharmaceuticals Company Information
6.13.2 Phio Pharmaceuticals Description and Business Overview
6.13.3 Phio Pharmaceuticals RNA Interference Technology Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Phio Pharmaceuticals RNA Interference Technology Product Portfolio
6.13.5 Phio Pharmaceuticals Recent Developments/Updates
6.14 Sirnaomics
6.14.1 Sirnaomics Company Information
6.14.2 Sirnaomics Description and Business Overview
6.14.3 Sirnaomics RNA Interference Technology Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Sirnaomics RNA Interference Technology Product Portfolio
6.14.5 Sirnaomics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 RNA Interference Technology Industry Chain Analysis
7.2 RNA Interference Technology Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 RNA Interference Technology Production Mode & Process Analysis
7.4 RNA Interference Technology Sales and Marketing
7.4.1 RNA Interference Technology Sales Channels
7.4.2 RNA Interference Technology Distributors
7.5 RNA Interference Technology Customer Analysis
8 RNA Interference Technology Market Dynamics
8.1 RNA Interference Technology Industry Trends
8.2 RNA Interference Technology Market Drivers
8.3 RNA Interference Technology Market Challenges
8.4 RNA Interference Technology Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Alnylam Pharmaceuticals
Arrowhead Pharmaceuticals
Astrazeneca plc
Bioneer Corporation
CureVac N.V.
Dicerna Pharmaceuticals
Gradalis Inc
Ionis Pharmaceuticals
Merck KGaA
Nutcracker Therapeutics
Phio Pharmaceuticals
Sirnaomics
Arcturus Therapeutics Holdings
Atalanta Therapeutics
List of Tables
 Table 1. Global RNA Interference Technology Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global RNA Interference Technology Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global RNA Interference Technology Market Competitive Situation by Manufacturers in 2024
 Table 4. Global RNA Interference Technology Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global RNA Interference Technology Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global RNA Interference Technology Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global RNA Interference Technology Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market RNA Interference Technology Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of RNA Interference Technology, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of RNA Interference Technology, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of RNA Interference Technology, Product Type & Application
 Table 12. Global Key Manufacturers of RNA Interference Technology, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global RNA Interference Technology by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Interference Technology as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global RNA Interference Technology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global RNA Interference Technology Sales by Region (2020-2025) & (K Units)
 Table 18. Global RNA Interference Technology Sales Market Share by Region (2020-2025)
 Table 19. Global RNA Interference Technology Sales by Region (2026-2031) & (K Units)
 Table 20. Global RNA Interference Technology Sales Market Share by Region (2026-2031)
 Table 21. Global RNA Interference Technology Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global RNA Interference Technology Revenue Market Share by Region (2020-2025)
 Table 23. Global RNA Interference Technology Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global RNA Interference Technology Revenue Market Share by Region (2026-2031)
 Table 25. North America RNA Interference Technology Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America RNA Interference Technology Sales by Country (2020-2025) & (K Units)
 Table 27. North America RNA Interference Technology Sales by Country (2026-2031) & (K Units)
 Table 28. North America RNA Interference Technology Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America RNA Interference Technology Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe RNA Interference Technology Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe RNA Interference Technology Sales by Country (2020-2025) & (K Units)
 Table 32. Europe RNA Interference Technology Sales by Country (2026-2031) & (K Units)
 Table 33. Europe RNA Interference Technology Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe RNA Interference Technology Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific RNA Interference Technology Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific RNA Interference Technology Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific RNA Interference Technology Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific RNA Interference Technology Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific RNA Interference Technology Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America RNA Interference Technology Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America RNA Interference Technology Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America RNA Interference Technology Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America RNA Interference Technology Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America RNA Interference Technology Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa RNA Interference Technology Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa RNA Interference Technology Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa RNA Interference Technology Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa RNA Interference Technology Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa RNA Interference Technology Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global RNA Interference Technology Sales (K Units) by Type (2020-2025)
 Table 51. Global RNA Interference Technology Sales (K Units) by Type (2026-2031)
 Table 52. Global RNA Interference Technology Sales Market Share by Type (2020-2025)
 Table 53. Global RNA Interference Technology Sales Market Share by Type (2026-2031)
 Table 54. Global RNA Interference Technology Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global RNA Interference Technology Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global RNA Interference Technology Revenue Market Share by Type (2020-2025)
 Table 57. Global RNA Interference Technology Revenue Market Share by Type (2026-2031)
 Table 58. Global RNA Interference Technology Price (US$/Unit) by Type (2020-2025)
 Table 59. Global RNA Interference Technology Price (US$/Unit) by Type (2026-2031)
 Table 60. Global RNA Interference Technology Sales (K Units) by Application (2020-2025)
 Table 61. Global RNA Interference Technology Sales (K Units) by Application (2026-2031)
 Table 62. Global RNA Interference Technology Sales Market Share by Application (2020-2025)
 Table 63. Global RNA Interference Technology Sales Market Share by Application (2026-2031)
 Table 64. Global RNA Interference Technology Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global RNA Interference Technology Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global RNA Interference Technology Revenue Market Share by Application (2020-2025)
 Table 67. Global RNA Interference Technology Revenue Market Share by Application (2026-2031)
 Table 68. Global RNA Interference Technology Price (US$/Unit) by Application (2020-2025)
 Table 69. Global RNA Interference Technology Price (US$/Unit) by Application (2026-2031)
 Table 70. Alnylam Pharmaceuticals Company Information
 Table 71. Alnylam Pharmaceuticals Description and Business Overview
 Table 72. Alnylam Pharmaceuticals RNA Interference Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Alnylam Pharmaceuticals RNA Interference Technology Product
 Table 74. Alnylam Pharmaceuticals Recent Developments/Updates
 Table 75. Arcturus Therapeutics Holdings Company Information
 Table 76. Arcturus Therapeutics Holdings Description and Business Overview
 Table 77. Arcturus Therapeutics Holdings RNA Interference Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Arcturus Therapeutics Holdings RNA Interference Technology Product
 Table 79. Arcturus Therapeutics Holdings Recent Developments/Updates
 Table 80. Arrowhead Pharmaceuticals Company Information
 Table 81. Arrowhead Pharmaceuticals Description and Business Overview
 Table 82. Arrowhead Pharmaceuticals RNA Interference Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Arrowhead Pharmaceuticals RNA Interference Technology Product
 Table 84. Arrowhead Pharmaceuticals Recent Developments/Updates
 Table 85. AstraZeneca Company Information
 Table 86. AstraZeneca Description and Business Overview
 Table 87. AstraZeneca RNA Interference Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. AstraZeneca RNA Interference Technology Product
 Table 89. AstraZeneca Recent Developments/Updates
 Table 90. Atalanta Therapeutics Company Information
 Table 91. Atalanta Therapeutics Description and Business Overview
 Table 92. Atalanta Therapeutics RNA Interference Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Atalanta Therapeutics RNA Interference Technology Product
 Table 94. Atalanta Therapeutics Recent Developments/Updates
 Table 95. Bioneer Corporation Company Information
 Table 96. Bioneer Corporation Description and Business Overview
 Table 97. Bioneer Corporation RNA Interference Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Bioneer Corporation RNA Interference Technology Product
 Table 99. Bioneer Corporation Recent Developments/Updates
 Table 100. CureVac N.V. Company Information
 Table 101. CureVac N.V. Description and Business Overview
 Table 102. CureVac N.V. RNA Interference Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. CureVac N.V. RNA Interference Technology Product
 Table 104. CureVac N.V. Recent Developments/Updates
 Table 105. Dicerna Pharmaceuticals Company Information
 Table 106. Dicerna Pharmaceuticals Description and Business Overview
 Table 107. Dicerna Pharmaceuticals RNA Interference Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Dicerna Pharmaceuticals RNA Interference Technology Product
 Table 109. Dicerna Pharmaceuticals Recent Developments/Updates
 Table 110. Gradalis Company Information
 Table 111. Gradalis Description and Business Overview
 Table 112. Gradalis RNA Interference Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Gradalis RNA Interference Technology Product
 Table 114. Gradalis Recent Developments/Updates
 Table 115. Ionis Pharmaceuticals Company Information
 Table 116. Ionis Pharmaceuticals Description and Business Overview
 Table 117. Ionis Pharmaceuticals RNA Interference Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Ionis Pharmaceuticals RNA Interference Technology Product
 Table 119. Ionis Pharmaceuticals Recent Developments/Updates
 Table 120. Merck KGaA Company Information
 Table 121. Merck KGaA Description and Business Overview
 Table 122. Merck KGaA RNA Interference Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Merck KGaA RNA Interference Technology Product
 Table 124. Merck KGaA Recent Developments/Updates
 Table 125. Nutcracker Therapeutics Company Information
 Table 126. Nutcracker Therapeutics Description and Business Overview
 Table 127. Nutcracker Therapeutics RNA Interference Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Nutcracker Therapeutics RNA Interference Technology Product
 Table 129. Nutcracker Therapeutics Recent Developments/Updates
 Table 130. Phio Pharmaceuticals Company Information
 Table 131. Phio Pharmaceuticals Description and Business Overview
 Table 132. Phio Pharmaceuticals RNA Interference Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Phio Pharmaceuticals RNA Interference Technology Product
 Table 134. Phio Pharmaceuticals Recent Developments/Updates
 Table 135. Sirnaomics Company Information
 Table 136. Sirnaomics Description and Business Overview
 Table 137. Sirnaomics RNA Interference Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Sirnaomics RNA Interference Technology Product
 Table 139. Sirnaomics Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. RNA Interference Technology Distributors List
 Table 143. RNA Interference Technology Customers List
 Table 144. RNA Interference Technology Market Trends
 Table 145. RNA Interference Technology Market Drivers
 Table 146. RNA Interference Technology Market Challenges
 Table 147. RNA Interference Technology Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of RNA Interference Technology
 Figure 2. Global RNA Interference Technology Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global RNA Interference Technology Market Share by Type: 2024 & 2031
 Figure 4. dsRNA Product Picture
 Figure 5. miRNA Product Picture
 Figure 6. Global RNA Interference Technology Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global RNA Interference Technology Market Share by Application: 2024 & 2031
 Figure 8. Drug Discovery and Development
 Figure 9. Diagnostic Centers
 Figure 10. Others
 Figure 11. Global RNA Interference Technology Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global RNA Interference Technology Market Size (2020-2031) & (US$ Million)
 Figure 13. Global RNA Interference Technology Sales (2020-2031) & (K Units)
 Figure 14. Global RNA Interference Technology Average Price (US$/Unit) & (2020-2031)
 Figure 15. RNA Interference Technology Report Years Considered
 Figure 16. RNA Interference Technology Sales Share by Manufacturers in 2024
 Figure 17. Global RNA Interference Technology Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest RNA Interference Technology Players: Market Share by Revenue in RNA Interference Technology in 2024
 Figure 19. RNA Interference Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global RNA Interference Technology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America RNA Interference Technology Sales Market Share by Country (2020-2031)
 Figure 22. North America RNA Interference Technology Revenue Market Share by Country (2020-2031)
 Figure 23. United States RNA Interference Technology Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada RNA Interference Technology Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe RNA Interference Technology Sales Market Share by Country (2020-2031)
 Figure 26. Europe RNA Interference Technology Revenue Market Share by Country (2020-2031)
 Figure 27. Germany RNA Interference Technology Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France RNA Interference Technology Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. RNA Interference Technology Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy RNA Interference Technology Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia RNA Interference Technology Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific RNA Interference Technology Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific RNA Interference Technology Revenue Market Share by Region (2020-2031)
 Figure 34. China RNA Interference Technology Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan RNA Interference Technology Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea RNA Interference Technology Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India RNA Interference Technology Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia RNA Interference Technology Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan RNA Interference Technology Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia RNA Interference Technology Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America RNA Interference Technology Sales Market Share by Country (2020-2031)
 Figure 42. Latin America RNA Interference Technology Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico RNA Interference Technology Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil RNA Interference Technology Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina RNA Interference Technology Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa RNA Interference Technology Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa RNA Interference Technology Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey RNA Interference Technology Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia RNA Interference Technology Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE RNA Interference Technology Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of RNA Interference Technology by Type (2020-2031)
 Figure 52. Global Revenue Market Share of RNA Interference Technology by Type (2020-2031)
 Figure 53. Global RNA Interference Technology Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of RNA Interference Technology by Application (2020-2031)
 Figure 55. Global Revenue Market Share of RNA Interference Technology by Application (2020-2031)
 Figure 56. Global RNA Interference Technology Price (US$/Unit) by Application (2020-2031)
 Figure 57. RNA Interference Technology Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

RNAi Technology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global circRNA Technology Market Research Report 2024
Global RNA Seq Market Research Report 2024
Global RNA Probe Market Research Report 2024
Global RNA Analysis Transcriptomic Market Research Report 2024
RNA Microarray Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global siRNA Drug Market Research Report 2024
RNA Cleanup Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Plasmid Market Research Report 2024
Global Small RNA Sequencing Market Research Report 2024
Global In Vitro Gene Therapy Market Research Report 2025
Global Carrier RNA Market Research Report 2025
Global RNA Interference RNAi Drug Delivery Market Research Report 2025
RNAi Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antisense and RNA Interference Therapeutics Market Research Report 2024
Global Interference Technology Solutions Market Research Report 2025
Global RNase Inhibitor Market Research Report 2025
Global RNA Interference RNAi Based Therapeutics Market Research Report 2024
Global Bacterial RNA Kit Market Research Report 2025
Global Nucleic Acid Nanotechnology Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions